Skip to content
10-Q

Quarterly Report

ARCUTIS BIOTHERAPEUTICS, INC. ARQT

0001787306-25-000124

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 119.91M sh
Shares Diluted Q2 2025 · Jun 30, 2025 127M sh
Shares Diluted Q2 2025 · Jun 30, 2025 126.52M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 123.48M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 117.27M sh
Capex Q2 2025 · Jun 30, 2025 $686K
Capex Q2 2025 · Jun 30, 2024 $0
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$30.06M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$76.72M
Long Term Debt Q2 2025 · Jun 30, 2025 $107.05M
Long Term Debt Q2 2025 · Dec 31, 2024 $107.2M
Short Term Debt Q2 2025 · Jun 30, 2025 $1M
Short Term Debt Q2 2025 · Dec 31, 2024 $0
Cash And Equivalents Q2 2025 · Jun 30, 2025 $72.74M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $71.34M
Stockholders Equity Q2 2025 · Jun 30, 2025 $138.97M
Stockholders Equity Q2 2025 · Mar 31, 2025 $142.66M
Stockholders Equity Q2 2025 · Dec 31, 2024 $157.54M
Stockholders Equity Q2 2025 · Jun 30, 2024 $186.43M
Stockholders Equity Q2 2025 · Mar 31, 2024 $224.94M
Stockholders Equity Q2 2025 · Dec 31, 2023 $88.67M
Current Liabilities Q2 2025 · Jun 30, 2025 $103.94M
Current Liabilities Q2 2025 · Dec 31, 2024 $81.01M
Total Liabilities Q2 2025 · Jun 30, 2025 $213.46M
Total Liabilities Q2 2025 · Dec 31, 2024 $191.35M
Current Assets Q2 2025 · Jun 30, 2025 $332.78M
Current Assets Q2 2025 · Dec 31, 2024 $335.82M
Total Assets Q2 2025 · Jun 30, 2025 $352.43M
Total Assets Q2 2025 · Dec 31, 2024 $348.89M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.13
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.32
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.42
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.75
Eps Basic Q2 2025 · Jun 30, 2025 −$0.13
Eps Basic Q2 2025 · Jun 30, 2025 −$0.32
Eps Basic Q2 2025 · Jun 30, 2024 −$0.42
Eps Basic Q2 2025 · Jun 30, 2024 −$0.75
Sga Expense Q2 2025 · Jun 30, 2025 $69.17M
Sga Expense Q2 2025 · Jun 30, 2025 $133.17M
Sga Expense Q2 2025 · Jun 30, 2024 $58.17M
Sga Expense Q2 2025 · Jun 30, 2024 $112.97M
Rd Expense Q2 2025 · Jun 30, 2025 $19.45M
Rd Expense Q2 2025 · Jun 30, 2025 $37M
Rd Expense Q2 2025 · Jun 30, 2024 $19.3M
Rd Expense Q2 2025 · Jun 30, 2024 $42.44M
Net Income Q2 2025 · Jun 30, 2025 −$15.89M
Net Income Q2 2025 · Jun 30, 2025 −$40.95M
Net Income Q2 2025 · Mar 31, 2025 −$25.06M
Net Income Q2 2025 · Jun 30, 2024 −$52.33M
Net Income Q2 2025 · Jun 30, 2024 −$87.71M
Net Income Q2 2025 · Mar 31, 2024 −$35.38M
Operating Income Q2 2025 · Jun 30, 2025 −$14.61M
Operating Income Q2 2025 · Jun 30, 2025 −$39.14M
Operating Income Q2 2025 · Jun 30, 2024 −$50.08M
Operating Income Q2 2025 · Jun 30, 2024 −$81.7M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $7.49M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $16.32M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $3.46M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $6.72M
Revenue Q2 2025 · Jun 30, 2025 $81.5M
Revenue Q2 2025 · Jun 30, 2025 $147.35M
Revenue Q2 2025 · Jun 30, 2024 $30.86M
Revenue Q2 2025 · Jun 30, 2024 $80.43M